NO983098L - Hudheftende farmas°ytisk preparat, spesielt transdermalt terapeutisk system for frigivelse av 17-<beta>-estradiol til den menneskelige organisme - Google Patents

Hudheftende farmas°ytisk preparat, spesielt transdermalt terapeutisk system for frigivelse av 17-<beta>-estradiol til den menneskelige organisme

Info

Publication number
NO983098L
NO983098L NO983098A NO983098A NO983098L NO 983098 L NO983098 L NO 983098L NO 983098 A NO983098 A NO 983098A NO 983098 A NO983098 A NO 983098A NO 983098 L NO983098 L NO 983098L
Authority
NO
Norway
Prior art keywords
estradiol
beta
release
pharmaceutical preparation
air humidity
Prior art date
Application number
NO983098A
Other languages
English (en)
Other versions
NO983098D0 (no
NO312878B1 (no
Inventor
Bodo Asmussen
Michael Horstmann
Original Assignee
Lohmann Therapie Syst Lts
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lohmann Therapie Syst Lts filed Critical Lohmann Therapie Syst Lts
Publication of NO983098L publication Critical patent/NO983098L/no
Publication of NO983098D0 publication Critical patent/NO983098D0/no
Publication of NO312878B1 publication Critical patent/NO312878B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
  • Materials For Medical Uses (AREA)
NO19983098A 1996-01-08 1998-07-03 Hudheftende farmasöytisk preparat, fremgangsmåte for fremstilling av samme, samt anvendelse av slike preparater NO312878B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19600347A DE19600347A1 (de) 1996-01-08 1996-01-08 Hauthaftende pharmazeutische Zubereitung, insbesondere TTS zur Abgabe von 17-beta-Estradiol an den menschlichen Organismus
PCT/EP1996/005822 WO1997025077A1 (de) 1996-01-08 1996-12-23 HAUTHAFTENDE PHARMAZEUTISCHE ZUBEREITUNG, INSBESONDERE TTS ZUR ABGABE VON 17-β-ESTRADIOL AN DEN MENSCHLICHEN ORGANISMUS

Publications (3)

Publication Number Publication Date
NO983098L true NO983098L (no) 1998-07-03
NO983098D0 NO983098D0 (no) 1998-07-03
NO312878B1 NO312878B1 (no) 2002-07-15

Family

ID=7782261

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19983098A NO312878B1 (no) 1996-01-08 1998-07-03 Hudheftende farmasöytisk preparat, fremgangsmåte for fremstilling av samme, samt anvendelse av slike preparater

Country Status (21)

Country Link
US (1) US6267982B1 (no)
EP (1) EP0880366B1 (no)
JP (1) JP2000505071A (no)
KR (1) KR100476579B1 (no)
CN (1) CN1107525C (no)
AT (1) ATE205406T1 (no)
AU (1) AU721677B2 (no)
CA (1) CA2242577C (no)
CZ (1) CZ289291B6 (no)
DE (2) DE19600347A1 (no)
DK (1) DK0880366T3 (no)
ES (1) ES2164270T3 (no)
HU (1) HUP9901102A3 (no)
IL (1) IL125160A (no)
MY (1) MY129733A (no)
NO (1) NO312878B1 (no)
NZ (1) NZ325817A (no)
PL (1) PL187275B1 (no)
SK (1) SK282984B6 (no)
WO (1) WO1997025077A1 (no)
ZA (1) ZA97111B (no)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6623763B2 (en) * 1996-01-08 2003-09-23 Lts Lohmann Therape-System Ag Pharmaceutical preparation adhering to the skin, in particular a transdermal therapeutic system for the release of 17-β-estradiol to the human organism
ES2373864T3 (es) * 1998-04-20 2012-02-09 Eisai R&D Management Co., Ltd. Composición estabilizada que contiene un compuesto de tipo bencimidazol.
DE19827732A1 (de) * 1998-06-22 1999-12-23 Rottapharm Bv Transdermales System vom Matrix-Typ zur Abgabe von Wirkstoffen mit einer hohen Abgaberate von Steroid-Hormonen und die Verwendung eines derartigen Systems zur Hormonersatztherapie
CA2401606A1 (en) * 2000-03-02 2001-09-07 Mcgill University Caspase-inhibitory-factor (cif) and uses thereof
JP4989892B2 (ja) * 2004-01-30 2012-08-01 久光製薬株式会社 貼付剤入り包装袋

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4863738A (en) * 1987-11-23 1989-09-05 Alza Corporation Skin permeation enhancer compositions using glycerol monooleate
ATE95059T1 (de) * 1989-02-28 1993-10-15 Teijin Ltd Pflaster sowie dessen herstellung.
IT1253265B (it) * 1991-11-25 1995-07-14 Rotta Research Lab Preparato a matrice copolimerica adesiva a base acrilica per il rilascio transdermico dell'estradiolo.
DE4223360C1 (no) * 1992-07-16 1993-04-08 Lts Lohmann Therapie-Systeme Gmbh & Co Kg, 5450 Neuwied, De
DE4237453C1 (no) * 1992-11-06 1993-08-19 Lts Lohmann Therapie-Systeme Gmbh & Co Kg, 5450 Neuwied, De
DE4405899A1 (de) * 1994-02-18 1995-08-24 Schering Ag Mittel zur transdermalen Applikation enthaltend Desogestrel
DE4429664C2 (de) * 1994-08-20 1997-09-11 Lohmann Therapie Syst Lts Estradiol-TTS mit wasserbindenden Zusätzen und Verfahren zu seiner Herstellung
DE4429667C2 (de) * 1994-08-20 1996-07-11 Lohmann Therapie Syst Lts Estradiol-TTS mit wasserbindenden Zusätzen und Verfahren zu seiner Herstellung

Also Published As

Publication number Publication date
ES2164270T3 (es) 2002-02-16
PL327940A1 (en) 1999-01-04
CN1207049A (zh) 1999-02-03
HUP9901102A3 (en) 1999-11-29
WO1997025077A1 (de) 1997-07-17
ZA97111B (en) 1997-08-18
AU1305797A (en) 1997-08-01
CA2242577C (en) 2006-06-06
PL187275B1 (pl) 2004-06-30
KR100476579B1 (ko) 2005-09-26
SK282984B6 (sk) 2003-01-09
NZ325817A (en) 1999-01-28
NO983098D0 (no) 1998-07-03
CA2242577A1 (en) 1997-07-17
KR19990077110A (ko) 1999-10-25
JP2000505071A (ja) 2000-04-25
US6267982B1 (en) 2001-07-31
AU721677B2 (en) 2000-07-13
CZ214098A3 (cs) 1998-11-11
MY129733A (en) 2007-04-30
IL125160A (en) 2003-01-12
ATE205406T1 (de) 2001-09-15
CZ289291B6 (cs) 2001-12-12
EP0880366B1 (de) 2001-09-12
DE19600347A1 (de) 1997-07-10
SK90898A3 (en) 1999-01-11
NO312878B1 (no) 2002-07-15
EP0880366A1 (de) 1998-12-02
DK0880366T3 (da) 2001-12-27
IL125160A0 (en) 1999-01-26
HUP9901102A2 (hu) 1999-08-30
CN1107525C (zh) 2003-05-07
DE59607696D1 (de) 2001-10-18

Similar Documents

Publication Publication Date Title
RU2176499C2 (ru) Композиция для чрескожного введения стероидных лекарственных средств и содержащий ее препарат
KR900005969A (ko) 게스토덴을 함유하는 경피 투여용 제제
CA2320132A1 (en) Pressure sensitive adhesive matrix patch for the treatment of onychomycosis
SE8801185L (sv) Transdermalt, terapeutiskt system
NZ228826A (en) Transdermal adhesive medicament containing eucalyptol (1,8 cineol)
GR3029308T3 (en) Medical device for the administration of active ingredients or drugs at very low doses, particularly homeopathic drugs.
HUP0302921A2 (hu) Hatóanyag perkután bejuttatására alkalmas alkoholos gélkészítmény, valamint ebből egységdózist tartalmazó csomag
AU2796192A (en) Device for administering drug transdermally with a controlled temporal change in skin flux
NO951765D0 (no) Transdermalt terapeutisk system for frigjöring av 17. radiol og fremgangsmåte for fremstilling derav
DE59308413D1 (de) Pflaster zur transdermalen verabreichung von flüchtigen, pharmazeutisch wirksamen, chemisch basischen inhaltsstoffen und verfahren zu seiner herstellung
SK280081B6 (sk) Transdermálny terapeutický systém a spôsob jeho vý
SE8401113D0 (sv) Forfarande for framstellning av pa huden fixerbara, krampstillande produkter, i synnerhet muskelkrampstillande forfarande for framstellning av pa huden fixerbara, krampstillande produkter, i synnerhet muskelkrampstillande
FI107705B (fi) Lanoliinijohdannaiset penetraatiota edistävinä aineina ja niiden käyttö lääkeaineita tai muita biologisesti aktiivisia aineita sisältävissä valmisteissa
Aqil et al. Fabrication and evaluation of polymeric films for transdermal delivery of pinacidil
NO983098D0 (no) Hudheftende farmas°ytisk preparat, spesielt transdermalt terapeutisk system for frigivelse av 17-&lt;beta&gt;-estradiol til den menneskelige organisme
KR20000029523A (ko) 치매치료및(또는)예방용제제
JPH04505333A (ja) ロリプラムを含有する皮膚浸透移行性適用剤
JPH0381217A (ja) 経皮吸収製剤
BR9912688A (pt) Emplastro contendo estradiol para aplicaçãotransdérmica de hormÈnios
RU2001102050A (ru) Лекарственная форма
AU2003235046A1 (en) Pressure sensitive adhesive matrix patch for the treatment of onychomycosis
MX9804617A (es) Preparacion farmaceutica estabilizada en la superficie para aplicarse sobre la piel.

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees